Skip to content

A pilot study of radio frequency renal denervation in treatment of hypertension

The safety and efficacy of renal artery radiofrequency ablation using a RDN system in treatment of hypertension: A pilot study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017779
Enrollment
Unknown
Registered
2018-08-14
Start date
2015-11-15
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Case series:Radio Frequency Renal denervation

Sponsors

Southeast University affiliated Zhongda Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Ages of 18 to 75, male or female; 2. Main renal artery, with or without accessary renal arteries, with length =20mm; 3. Patients who have not taken any anti-hypertensive drugs or have been off drugs for at least 2 weeks, with mean SBP =150mmHg and =180mmHg based on at least 3 office blood pressure measurements, or ASBP=135mmHg and =170mmHg based on 24 hr blood pressure monitoring; 4. Agrees to take part in the trial and signs the written, informed consent.

Exclusion criteria

Exclusion criteria: 1. Renal artery abnormalities that are inappropriate for the procedure; 2. Pregnant or plan to become pregnant; 3. History of orthostatic hypotension; 4. Type I diabetes; 5. Estimated GFR<40mL/min/1.73m2; 6. Only one kidney or prior kidney transplantation; 7. Bleeding tendency or other coagulation related diseases; 8. Acute or severe systemic infection; 9. Prior renal artery interventional procedures or prior RDN treatment; 10. History of stroke or TIA; 11. Malignant tumor or end-stage illnesses; 12. Secondary hypertension; 13. Acute coronary events within 2 weeks; 14. Other conditions that deem unsuitable for the procedure, in the opinions of investigators.

Design outcomes

Primary

MeasureTime frame
Blood Pressure;

Countries

China

Contacts

Public ContactMa Gen-Shan

Southeast University affiliated Zhongda Hospital

magenshan@qq.com+86 13002580569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026